Cargando…

15017 Monoclonal antibody use in rheumatoid arthritis: an evaluation of medical expenditure

ABSTRACT IMPACT: Younger patients receiving biologics for rheumatoid arthritis have higher medical expenditure. OBJECTIVES/GOALS: TNF inhibiting biologic disease modifying antirheumatic drugs are among the most highly regarded treatment options for rheumatoid arthritis (RA). We aimed at evaluating t...

Descripción completa

Detalles Bibliográficos
Autores principales:	Kelly, Robert A., Ceacareanu, Alice C., Wintrob, Zachary A.P.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Cambridge University Press 2021
Materias:	Clinical Epidemiology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8827817/ http://dx.doi.org/10.1017/cts.2021.478

Ejemplares similares

56600 Statin use and medical expenditure in patients with Parkinson’s disease
por: Lo Piccolo, Anthony J., et al.
Publicado: (2021)

53034 Melatonin use and occurrence of respiratory illnesses
por: Bowen, Hannah M., et al.
Publicado: (2021)

67863 Insulin use and depigmentation: a survey of real-world evidence
por: Lukasik, James, et al.
Publicado: (2021)

Summary of COVID-19 Vaccine-Related Reports in the Vaccine Adverse Event Reporting System
por: Ceacareanu, Alice C., et al.
Publicado: (2021)

Missing the Benefit of Metformin in Acute Myeloid Leukemia: A Problem of Contrast?
por: Ceacareanu, Alice C., et al.
Publicado: (2017)

Adalimumab, a human anti-TNF monoclonal antibody, outcome study for the prevention of joint damage in Japanese patients with early rheumatoid arthritis: the HOPEFUL 1 study
por: Takeuchi, Tsutomu, et al.
Publicado: (2014)

A CLEC16A variant confers risk for juvenile idiopathic arthritis and anti-cyclic citrullinated peptide antibody negative rheumatoid arthritis
por: Skinningsrud, Beate, et al.
Publicado: (2010)

Mavrilimumab, a human monoclonal antibody targeting GM-CSF receptor-α, in subjects with rheumatoid arthritis: a randomised, double-blind, placebo-controlled, phase I, first-in-human study
por: Burmester, Gerd R, et al.
Publicado: (2011)

Impact of tocilizumab therapy on antibody response to influenza vaccine in patients with rheumatoid arthritis
por: Mori, Shunsuke, et al.
Publicado: (2012)

Dataset on growth factor levels and insulin use in patients with diabetes mellitus and incident breast cancer
por: Wintrob, Zachary A.P., et al.
Publicado: (2017)

TH1 and TH2 cytokine data in insulin secretagogues users newly diagnosed with breast cancer
por: Wintrob, Zachary A.P., et al.
Publicado: (2017)

Circulating growth factors data associated with insulin secretagogue use in women with incident breast cancer
por: Wintrob, Zachary A.P., et al.
Publicado: (2017)

Insulin use, hormone receptor status and hematopoietic cytokines׳ circulation in women with diabetes mellitus and breast cancer
por: Wintrob, Zachary A.P., et al.
Publicado: (2017)

Dataset on granulopoiesis- and lymphopoiesis-stimulating cytokine levels in insulin secretagogue users with incident breast cancer
por: Wintrob, Zachary A.P., et al.
Publicado: (2017)

TH1 and TH2 cytokines dataset in insulin users with diabetes mellitus and newly diagnosed breast cancer
por: Wintrob, Zachary A.P., et al.
Publicado: (2017)

Genetic markers of rheumatoid arthritis susceptibility in anti-citrullinated peptide antibody negative patients
por: Viatte, Sebastien, et al.
Publicado: (2012)

Application of a Pharmacokinetic Model of Metformin Clearance in a Population with Acute Myeloid Leukemia
por: Ceacareanu, Alice C., et al.
Publicado: (2018)

Ofatumumab, a fully human anti-CD20 monoclonal antibody, in biological-naive, rheumatoid arthritis patients with an inadequate response to methotrexate: a randomised, double-blind, placebo-controlled clinical trial
por: Taylor, Peter C, et al.
Publicado: (2011)

Long-term safety and efficacy of tocilizumab, an anti-IL-6 receptor monoclonal antibody, in monotherapy, in patients with rheumatoid arthritis (the STREAM study): evidence of safety and efficacy in a 5-year extension study
por: Nishimoto, N, et al.
Publicado: (2009)

Evaluation of the anti-RANKL monoclonal antibody in rheumatoid arthritis rats
por: Lv, Dawei, et al.
Publicado: (2022)

Statin Type and Cancer Outcomes in Patients with Diabetes Type 2 and Solid Tumors
por: Ceacareanu, Alice C., et al.
Publicado: (2021)

Sirukumab, a human anti-interleukin-6 monoclonal antibody: a randomised, 2-part (proof-of-concept and dose-finding), phase II study in patients with active rheumatoid arthritis despite methotrexate therapy
por: Smolen, Josef S, et al.
Publicado: (2014)

Circulating adipokines data associated with insulin secretagogue use in breast cancer patients
por: Wintrob, Zachary A.P., et al.
Publicado: (2016)

Insulin secretagogue use and circulating inflammatory C–C chemokine levels in breast cancer patients
por: Wintrob, Zachary A.P., et al.
Publicado: (2017)

Pharmacogenomics of Monoclonal Antibodies for the Treatment of Rheumatoid Arthritis
por: Lim, Sung Ho, et al.
Publicado: (2022)

Biologic refractory disease in rheumatoid arthritis: results from the British Society for Rheumatology Biologics Register for Rheumatoid Arthritis
por: Kearsley-Fleet, Lianne, et al.
Publicado: (2018)

Efficacy and safety of mavrilimumab in subjects with rheumatoid arthritis
por: Burmester, Gerd R, et al.
Publicado: (2013)

MOR103, a human monoclonal antibody to granulocyte–macrophage colony-stimulating factor, in the treatment of patients with moderate rheumatoid arthritis: results of a phase Ib/IIa randomised, double-blind, placebo-controlled, dose-escalation trial
por: Behrens, Frank, et al.
Publicado: (2015)

Changes in the anticitrullinated peptide antibody response in relation to therapeutic outcome in early rheumatoid arthritis: results from the SWEFOT trial
por: Kastbom, Alf, et al.
Publicado: (2016)

Sarilumab, a fully human monoclonal antibody against IL-6Rα in patients with rheumatoid arthritis and an inadequate response to methotrexate: efficacy and safety results from the randomised SARIL-RA-MOBILITY Part A trial
por: Huizinga, Tom W J, et al.
Publicado: (2014)

Overlap of disease susceptibility loci for rheumatoid arthritis and juvenile idiopathic arthritis
por: Hinks, Anne, et al.
Publicado: (2010)

Infliximab improves vascular stiffness in patients with rheumatoid arthritis
por: Wong, M, et al.
Publicado: (2008)

Prevalence of comorbidities in rheumatoid arthritis and evaluation of their monitoring: results of an international, cross-sectional study (COMORA)
por: Dougados, Maxime, et al.
Publicado: (2014)

Emerging therapies in rheumatoid arthritis: focus on monoclonal antibodies
por: Senolt, Ladislav
Publicado: (2019)

Smoking and overweight determine the likelihood of developing rheumatoid arthritis
por: de Hair, Maria J H, et al.
Publicado: (2013)

Comprehensive assessment of rheumatoid arthritis susceptibility loci in a large psoriatic arthritis cohort
por: Bowes, John, et al.
Publicado: (2012)

Malignancies in the rheumatoid arthritis abatacept clinical development programme: an epidemiological assessment
por: Simon, T A, et al.
Publicado: (2009)

Treating Rheumatoid Arthritis to Target: multinational recommendations assessment questionnaire
por: Haraoui, Boulos, et al.
Publicado: (2011)

Data report on inflammatory C–C chemokines among insulin-using women with diabetes mellitus and breast cancer
por: Wintrob, Zachary A.P., et al.
Publicado: (2017)

Investigation of rheumatoid arthritis susceptibility loci in juvenile idiopathic arthritis confirms high degree of overlap
por: Hinks, Anne, et al.
Publicado: (2012)

Cannot write session to /tmp/vufind_sessions/sess_ikf2931fkuhqml68aop0c8800e